Holds one active US DMF for brexpiprazole, filing since 2022. Its 2024 FDA inspection closed as VAI.
Holds one active US DMF for brexpiprazole, filing since 2024. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for brexpiprazole, filing since 2024.
Holds one active US DMF for brexpiprazole, filing since 2026.
Holds one active US DMF for brexpiprazole, filing since 2019. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 1 market.
This page filters the worldwide Brexpiprazole manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for brexpiprazole and what filings they hold.
Chat with Fred, your AI analyst